来自AHA科学会议的关键高血压突破和新兴趋势
Sashwath Srikanth1, Avilash Mondal2, Sanjana Aggarwal3
1Department of Internal Medicine, East Carolina University Greenville, NC, USA.
Current problems in cardiology
|February 3, 2024
概括
新的高血压管理策略,包括更严格的血压目标和像Zilebesiran这样的新药,在全球不同的人口中显示出希望. 这些进步可以改善心血管健康和认知功能,特别是在服务不足的社区.
科学领域:
- 心血管医学 心血管医学
- 公共卫生 公共卫生
- 药理学 药理学是指药理学的学科.
背景情况:
- 高血压仍然是一个全球性的健康挑战,需要创新的管理策略.
- 最近的研究探讨了更严格的血压目标和各种不同人群的各种干预措施.
- 了解社会经济因素和地理环境对高血压治疗的影响至关重要.
研究的目的:
- 总结了在2023年美国心脏协会会议上提出的晚期高血压管理策略.
- 要突出专注于更严格的血压目标和它们在不同人群中的应用的试验.
- 评估高血压新药学和非药学干预措施的疗效和安全性.
主要方法:
- 从2023年AHA会议中选择的晚期突破科学的审查.
- 分析了包括中国农村医疗保健项目 (CRHCP),CARDIA-SSBP,POP-HT,KARDIA-1,ESPRIT和IMPACTS试验在内的研究.
- 包括现实世界的实施研究,如尼日利亚高血压治疗计划.
主要成果:
- 更严格的血压目标可能会降低痴呆症发病率 (CRHCP).
- 减少可以有效降低缩血压 (心脏-SSBP).
- 产后妇女从自我监测和优化抗高血压剂定位 (POP-HT) 中受益.
- 齐勒贝西兰显示出持续降低血压的潜力 (KARDIA-1).
- 强化降低血压在各种人群中显示出好处,包括服务不足的地区 (SPRINT,ESPRIT,IMPACTS).
结论:
- 新型高血压管理策略,包括更严格的目标和新药,显示出巨大的潜力.
- 干预措施在全球不同的人口和社会经济环境中是有效的.
- 即使在资源较低的环境中,实施综合战略也可以改善公共卫生结果.
相关概念视频
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Errors occurring during blood pressure monitoring
727
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
727
Factors affecting Blood pressure
3.2K
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Physiological Factors:
3.2K
Alterations in Blood Pressure
1.2K
Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
1.2K
Measurement of Blood Pressure
931
Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a...
931
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
167
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
167


